This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Trade & Channel Strategies
See you in 2023! Stay tuned for dates and announcements!
December 12-14, 2023Philadelphia, PA

Stanton Mehr
Director of Content at Biosimilars Review & Report


The principal behind Biosimilar Review & Report, Stanton Mehr, is a veteran consultant, observer, and writer in the health care industry. Stan has decades of experience publishing on the pharmaceutical, managed care, and health policy areas. He has been reporting and consulting on the biosimilar industry since 2013, first as the founding content developer for the Center for Biosimilars, and then as Content Director for BR&R.

He has presented on several biosimilar topics; helped organize a biosimilar summit among payer representatives, academics, consultants, and employer representatives. He is also on the Editorial Advisory Board of the Journal of Managed Care and Specialty Pharmacy.

Stan Mehr has more than 30 years of experience in health care publishing and project management, specializing in the payer markets, clinical issues, health policy, and health delivery. He spent 20 years as Executive Vice President and Editorial Director of Medicom International Inc, where he was the Founding Editor of Managed Care Interface, the first monthly, peer-reviewed journal for the managed care industry, and its sister publication Long-Term Care Interface.

Agenda Sessions

  • Current Trends and Changes Impacting Biosimilars